Delivery Order SPE2DB22D3016-SPE2DB25FBKE9
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,639.28 delivery order on September 17, 2025, for Sandostatin LAR Depot 20 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This competitively awarded, firm fixed-price contract represents an individual delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $24,528.04 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Sandostatin LAR Depot is a long-acting somatostatin analog used in the treatment of acromegaly and neuroendocrine tumors,...
- The Defense Logistics Agency awarded a delivery order valued at $38,625.42 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, completed on May 20, 2025. Sandostatin LAR Depot is a long-acting injectable formulation of octreotide used primarily for managing acromegaly and neuroendocrine tumors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,958.92 for Sandostatin LAR Depot 20 mg kits on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a firm fixed price contract with no set-aside designation, representing a competitively awarded delivery order under the company's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a $10,639.28 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Sandostatin LAR Depot 20 mg kits, with performance completion targeted for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sandostatin LAR Depot 20 mg kits under a firm fixed-price contract valued at $21,278.56. This is a competitive award with no set-aside designation, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of August 13, 2025. The delivery order is a child contract under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Sandostatin LAR Depot 20 mg kits valued at $62,713.64 with firm fixed pricing. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a $159,383.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $79,481.42 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 20 mg kits under a firm fixed-price contract. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. Sandostatin LAR...
- The Defense Logistics Agency awarded a delivery order valued at $21,594.51 to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product used in the treatment of acromegaly and neuroendocrine tumors. This competitively awarded, firm fixed-price delivery order, issued on May 23, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...